Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial

Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Glossary toggle is now shown on the page. Minor textual updates include capitalization changes for 'Last Update Submitted' and 'No FEAR Act data', and a new revision label v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T07:35:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Sponsor field updated from FibroGen to Kyntra Bio. FibroGen is no longer listed as sponsor.
    Difference
    0.3%
    Check dated 2026-01-22T05:00:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 added and Revision: v3.3.3 removed, indicating a minor internal version update. This change does not affect study details, eligibility criteria, or how a user interacts with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:11:06.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    New Locations section added listing participating sites by state (Arizona, California, District of Columbia, Florida, Louisiana, Minnesota, Pennsylvania, Washington). The HHS Vulnerability Disclosure footer link was removed.
    Difference
    0.9%
    Check dated 2025-12-24T14:48:11.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    Footer revision text updated from Revision: v3.2.0 to Revision: v3.3.2; overall page content and layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:57:47.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page removed a generic government funding status notice; this is a non-critical change that does not affect the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T11:17:06.000Z thumbnail image

Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.